3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
4
Leukemia, Myelomonocytic, Acute
3
Leukemia, Monocytic, Acute
3
Leukemia, Megakaryoblastic, Acute
3
Leukemia, Erythroblastic, Acute
3
Prostatic Neoplasms
2
Mouth Neoplasms
2
Congenital Abnormalities
2
Carcinoma, Non-Small-Cell Lung
2
Squamous Intraepithelial Lesions
1
Smoldering Multiple Myeloma
1
Sarcoma, Synovial
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Prostate Adenocarcinoma
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Osteoporosis
1
Oropharyngeal Neoplasms
1
Obesity
1
Neurofibrosarcoma
1
Neuroblastoma
1
Neoplasms, Plasma Cell
1
Multiple Myeloma
1
Melanoma
1
Malignant mesenchymal tumor
1
Lymphoma, Mantle-Cell
1
Lymphoma
1
Lung Neoplasms
1
Liposarcoma
1
Interventions
Brentuximab Vedotin
13
fludarabine
8
Cyclophosphamide
8
Rituximab
6
ruxolitinib
5
fludarabine phosphate
5
Melphalan
5
Lenalidomide
5
ponatinib
4
Dexamethasone
4
Busulfan
4
Bortezomib
4
nilotinib
3
Whole-Body Irradiation
3
Vincristine
3
Prednisone
3
Mycophenolic Acid
3
Imatinib Mesylate
3
Doxorubicin
3
Bendamustine Hydrochloride
3
Alemtuzumab
3
vosaroxin
2
pomalidomide
2
Tacrolimus
2
Sugars
2
Stem Cell Transplantation
2
Sirolimus
2
Ondansetron
2
Leukapheresis
2
Granulocyte Colony-Stimulating Factor
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Hematologic Diseases
×
Observation
×
Clear all
No trials found.